spacer
home > events calendar > more about event
PHARMACEUTICAL INDUSTRY EVENTS CALENDAR

BioTrinity 2018

BioTrinity 2018

23-25 April 2018
Novotel London West in Hammersmith

BioTrinity 2018 is taking place from 23-25 April at the Novotel London West in Hammersmith. Now in its 12th year, BioTrinity remains the leading life sciences biopartnering and investment conference in Europe, and is a must attend event for R&D companies, TTO’s and academia who are looking to meet, collaborate, partner and seek funding from Big Pharma, Investors and Associated Industry companies.

Each year we seek to improve and evolve the format of the conference in-line with industry trends and to meet the changing demands of our delegates, with key highlights including:

·        Over 2,000 private partnering meetings supported by the partneringONE™ booking system

·        Innovative and insightful programme of keynote presentations, panel discussions and round table debates exploring the latest hot topics in the industry

·        BioLaunchPad™ - a single track series of Company Showcase presentations, all in one room, with an audience capacity of up to 200

·        An improved environment in the partnering area including additional lounge areas and branded coffee stands

·        Refined programme of networking events to further support collaboration and partnership opportunities between delegates.

Our theme for BioTrinity 2018 is ‘Next Generation Healthcare’ which we will explore via a range of insightful keynote and panel discussions including ‘AI and Drug Discovery’, ‘An insight into Nanotechnology’, ‘Next Generation Chemistry’ and ‘Fintech and the Future of the Investment Industry’ – more updates on speakers and topics will follow soon.

A general delegate ticket includes access to the whole conference, including the use of the partneringONE™ meeting scheduler, access to keynote and panel discussions, BioLaunchPad™ company showcase presentations, all social networking events and full catering throughout the conference.
Special rates are available to OBN Members, who can save up to £300 per delegate. Please contact our Membership Manager (Nicola Westgate – nicola.westgate@obn.org.uk) to find out if you are eligible for a member rate or to enquire about becoming an OBN Member. Please note that ticket prices increase in the run-up to the event – the earlier you book, the more money you save!

Please visit www.biotrinity.comfor up to date information.

Organiser contact details:

OBN Events Team
events@obn.org.uk

phone +44 (0) 1235 420 879
email events@obn.org.uk
web www.biotrinity.com
email Novotel London West, 1 Shortlands, Hammersmith, London, W6 8DR
 
Print this page
Send to a friend
   
spacer
Industry Events

Clinical Trial Supply Southeast 2018

2-3 October 2018, Cary, North Carolina

Clinical Trial Supply Southeast will return to Cary, North Carolina for fall 2018. Part of our global series of events, this show will attract the leading biotech and pharma companies from the Southeast region, the event will focus on how companies can adapt their supply chains to fit into the highly regulated world.
More info >>

White Papers

Challenges of Analytical Method Transfer in the Pharmaceutical Industry

RSSL

The development and validation of suitable analytical methods is a critical part of the overall drug-development life-cycle. For the majority of products, particularly those that are clinically successful, the transfer of the analytical method between laboratories will be required. This process is designed to verify that a given laboratory is capable of performing a test method for its intended purpose. This can be performed either internally (at the same company), or, with the on-going increasing trend in outsourcing, to an external Contract Research or Development organisation (CRO or CDO).
More info >>


News and Press Releases

Phenomenex Introduces bioZen Series for Characterization of Biotherapeutics

Torrance, Calif. (April 16, 2018) – Phenomenex Inc., a global leader in the research and manufacture of advanced technologies for the separation sciences, introduces bioZen – a new series of LC solutions for bioseparations in pharmaceutical, biopharmaceutical and academic research. The series encompasses both proven and entirely new media spanning two particle platforms – core-shell and thermally modified fully porous – along with new biocompatible titanium hardware. The initial bioZen product line features seven chemistries for the UHPLC and HPLC characterization of biotherapeutics such as monoclonal antibodies, antibody-drug conjugates and biosimilars. The offering includes specific LC chemistries for the analysis of aggregates and total mAb, intact mass and fragments, peptide mapping and quantitation and glycan mapping.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement